These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Essential phospholipids in the treatment of chronic pyelonephritis].
    Author: Ovchinnikov AA, Tsvettsikh VE, Berdichevskiĭ BA, Lykov VN, Suktanbaev VR, Murychev AV.
    Journal: Urol Nefrol (Mosk); 1996; (4):7-9. PubMed ID: 8928353.
    Abstract:
    The author's investigations led them to the conclusion that clinical manifestation of chronic pyelonephritis is associated with destabilization of lipid bilayer of red cell membranes, renal tissue, activation of lipid peroxidation (LPO), rising lipid and LPO products excretion with the urine. 31 patients with chronic pyelonephritis received combined therapy comprising essential phospholipids. 25 control patients with the same disease were not given essentiale-forte. Finally, the latter had longer fever duration, more active inflammation. The former had also low urine excretion of oxalates and normal lipid composition of biological membranes.
    [Abstract] [Full Text] [Related] [New Search]